Aerolase
Aerolase builds compact, single-handpiece 1064nm Nd:YAG lasers — led by the Neo Elite — that treat 36+ indications and are notably safe across all Fitzpatrick skin types, making them a favorite of med spas with diverse clientele.

Broad multi-application device maker with subscription-style acquisition
A broad, innovative multi-application portfolio with the industry's most flexible acquisition model — but ongoing net losses and restructuring mean buyers must contractually protect long-term service before committing.
Venus Concept is a publicly traded (NASDAQ: VERO) aesthetic device manufacturer headquartered in Toronto with substantial US operations. Its portfolio is one of the broadest in the industry: the Venus Versa Pro multi-application IPL workstation, the Venus Bliss MAX body platform, the Venus Viva RF resurfacing system, and the Venus NOVA, which received FDA clearance in November 2025. The company built its market position on an unusually accessible commercial model — subscription-style device acquisition that lets practices pay for equipment over time rather than committing full capital up front, alongside conventional quotes and financing.
The honest caveat is financial: Venus Concept has posted ongoing net losses and has been restructuring, including divesting its hair-restoration business to refocus on core aesthetics. None of that changes what the devices do clinically, but it does bear directly on the long-term service, parts and upgrade commitments a device buyer depends on for a 7-to-10-year asset. Practices attracted to the broad portfolio and flexible acquisition terms should stress-test service guarantees, escrow or continuity provisions, and consumable availability before signing.
Ideal customer
Budget-conscious med spas and new practices that want a broad, multi-application device lineup with lower upfront capital via subscription-style acquisition — and that are willing to do extra diligence on long-term service given the company's financial restructuring.
Venus Concept occupies a distinctive position in aesthetic equipment: a broad-portfolio manufacturer with the industry's best-known subscription-style acquisition model. Headquartered in Toronto with substantial US operations and listed on NASDAQ (VERO), the company sells multi-application workhorses — the Venus Versa Pro IPL platform, the Venus Bliss MAX body system, the Venus Viva RF resurfacing device — and continues to ship new technology, most recently the Venus NOVA, FDA-cleared in November 2025.
The commercial model is the headline. Where legacy manufacturers demand six-figure capital outlays, Venus built its growth on letting practices acquire devices through monthly subscription-style payments. For a new med spa or a practice testing a new treatment category, that materially lowers the barrier to entry.
The central issue is financial stress, and what it means for support. Venus Concept has posted ongoing net losses and has been restructuring, including divesting its hair-restoration business to refocus on core aesthetics. To be clear: this is a factual observation from public filings, not a prediction of failure — but a med spa device is a 7-to-10-year asset, and its value depends on the manufacturer's ability to service it, supply parts and honor warranties for that entire period. Cost pressure on a company inevitably touches field service and training organizations first. We have tempered our Support score accordingly, and we recommend buyers negotiate explicit service-continuity protections: guaranteed parts availability windows, defined field-response SLAs, and clarity on what happens to service obligations in any change-of-control scenario.
Secondarily, read subscription paperwork carefully. Monthly acquisition is attractive, but total cost over the full term can exceed an outright financed purchase, and end-of-term ownership, upgrade rights and early-exit provisions vary by deal.
Choose Venus Concept if upfront capital is your binding constraint and you want broad, multi-application coverage from one vendor — the subscription model remains one of the most accessible on-ramps into device-based aesthetics, and platforms like Versa Pro and Bliss MAX are proven menu workhorses. Go in with eyes open: read the latest VERO filings, get service commitments in writing, and price the subscription against a conventional financed purchase over the full term. Practices that prioritize maximum long-term vendor stability above acquisition flexibility should weigh manufacturers on firmer financial footing, or a distributor like Cartessa, alongside this one.
By Med Spa Vendor Hub Editorial Team. Last reviewed June 29, 2026. Independent editorial review — how we score.
All devices are quoted individually. Venus Concept's differentiator is its subscription-style acquisition model — monthly payments over a multi-year term instead of a full upfront capital purchase — alongside conventional financing. Read subscription terms carefully: total cost over the term, end-of-term ownership, upgrade rights and early-termination provisions all vary by deal. Given the company's restructuring, negotiate explicit service-continuity and parts-availability protections.
Custom quote
Custom quote
per device
Quoted per platform, with either conventional purchase/financing or Venus's subscription-style monthly acquisition plan; service, consumables and upgrade terms negotiated per deal.
Pricing is researched from public sources and verified periodically; confirm current rates with the vendor.
A vendor-neutral guide to choosing aesthetic devices for a med spa—covering the device categories that define your menu, manufacturer vs distributor vs certified pre-owned, FDA clearance and state delegation rules, vendor financial stability, and the ROI math that decides whether a platform pays.
Aesthetic devices run from ~$25k entry systems to $200k+ premium platforms, and the sticker is only the first layer. Here's a transparent 2026 breakdown of typical price bands, consumables, financing, service contracts, and a worked ROI example - all quote-based, so confirm with vendors.
Aerolase builds compact, single-handpiece 1064nm Nd:YAG lasers — led by the Neo Elite — that treat 36+ indications and are notably safe across all Fitzpatrick skin types, making them a favorite of med spas with diverse clientele.
Alma Lasers is a global multi-application aesthetic-device manufacturer best known for the Soprano painless diode hair-removal franchise, alongside Harmony XL Pro, Accent Prime and Opus — a huge worldwide install base with a mixed direct/distributor sales model.
Astanza Laser is the US leader in tattoo-removal lasers (Duality, Trinity) and multi-platform aesthetic devices, now the exclusive US distributor for Italy's Quanta System — backed by unusually strong training and marketing support.